Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

Topic: Janet Woodcock

Latest Headlines

FDA's Woodcock discusses pain management
FDA's Woodcock discusses pain management
WASHINGTON, Nov. 30 (UPI) -- The U.S. Food and Drug Administration says it is trying to strike a balance between access to pain medications and the associated risks posed by analgesics.
U.S. drug approval head conflict probed
WASHINGTON, Aug. 12 (UPI) -- A California complaint has led to a conflict-of-interest investigation involving the head of U.S. drug approvals, the Food and Drug Administration confirms.
FDA and Europe adopt joint drug policy
WASHINGTON, June 12 (UPI) -- The U.S. Food and Drug Administration and the European Medicines Association say they plan to work together in assessing the safety of new drugs.
FDA: Switch to HFA-propelled inhaler
WASHINGTON, May 30 (UPI) -- The U.S. Food and Drug Administration issued a public health advisory that chlorofluorocarbon, or CFC-propelled inhalers will not be available next year.
FDA official, Democrats spar on drug plan
WASHINGTON, May 2 (UPI) -- A top U.S. Food and Drug Administration official reportedly has refused to support Democrats on tougher inspection plans.
FDA thinks heparin contaminated on purpose
WASHINGTON, April 29 (UPI) -- The U.S. Federal Drug Administration said Tuesday it suspects contamination of the blood thinner heparin that led to 81 deaths was deliberate.
Tainted heparin found overseas
WASHINGTON, April 22 (UPI) -- U.S. regulators said contaminated blood thinner from China, linked to 81 deaths in the United States, has been found in several countries.
Health insurer to track drug safety
INDIANAPOLIS, April 16 (UPI) -- A major U.S. health insurer says it is developing a program to monitor the safety of drugs after they have been approved for market.
FDA identifies heparin contaminant
WASHINGTON, March 20 (UPI) -- The U.S. Food and Drug Administration says the contaminant found in Baxter International's heparin blood thinner is oversulfated chondroitin sulfate.
FDA names drug research chief
WASHINGTON, March 11 (UPI) -- The U.S. Food and Drug Administration has selected Dr. Janet Woodcock to become the agency's director of drug evaluation and research.
view more

Quotes

“ We need to work with pharmacy operators, drug manufacturers, healthcare professionals and consumers to come up with a sensible, comprehensive and more effective solution, ”
FDA criticizes medication information
United Press International
“ We cannot rule out, however, that some of these patients were dehydrated prior to ingestion of OSP products or they did not drink sufficient fluids after ingesting OSP products, ”
FDA orders bowel cleanser safety warnings
United Press International
“ As part of FDA's monitoring of the life-cycle of approved products, the agency received reports of serious infections in some patients taking Raptiva, These reports led to our decision to highlight these risks in the drugs labeling, ”
FDA OKs Raptiva drug labeling changes
United Press International
“ My message to patients is this: Don't stop taking your medicine. If your doctor has prescribed a drug that appears on this list, you should continue taking it unless your doctor advises you differently, ”
FDA posts drug-safety watch list
United Press International
“ Modern science has advanced since, and this is an opportunity to apply modern science to evaluate these products, ”
Children medicines to be reviewed
United Press International
view more
Most Popular
Stories Photos People Comments
Featured Photos
1 of 20
Syrians Protest Against the President Bashar al-Assad
View Caption